Navigation Links
GENova gains access to Big Pharma
Date:9/15/2009

sults or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. GENova appoints Director of Asian business development
7. GENova files patent for new breast cancer treatment
8. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
9. GENova issues clarifying press release
10. GENova appoints Dr. Philip Gould to Scientific Advisory Board
11. GENova appoints Dr. Wang Chong to Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...reduce differences in incidence, deaths, research ...ws) -- Efforts to prevent teens from smoking have ...incidence and death rates among adults in the Unit...st lung cancer cases in the United States. Lung ca... than in whites at all ages. Since the 1970s, prog...
(Date:12/3/2009)...s Foundation bestowed its highest nationwide honor...nal meeting in Atlanta. , ...ion bestowed its highest nationwide honors to seve...ng on Nov. 20 in Atlanta. The honorees are as fol...hed Service ,The Arthritis Foundation honored Laur...
(Date:12/3/2009)...k receives President’s Service Award. , ... 2009 -- CS3 Technology, a leading professional se...businesses across the country, is pleased to annou... their company-wide retreat, CS3 recognizes outsta...r, Cindi Kessock earned the President’s Serv...
(Date:12/3/2009)...t RN, hopes to cheer up children during the holida...“Little Big Wolf,” and “Grin&rsq...go to children’s hospitals nationwide. , ... Carlton Scott RN , hopes to bring holiday cheer ... self-illustrated picture books. Having already so...
(Date:12/3/2009)...ve pound gift anywhere in the world can easily set...de postage is free when you send an upscale Americ....oakanahouse.com . , (PRW...to Paris, Perth or Punjab can easily set you back ... can keep in their pocket when gift buyers purchas...
Breaking Medicine News(10 mins):Health News:Lung Cancer's Racial Gap Narrowing 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Traveling Nurse Cheers up Kids with Handmade Books 2Health News:Traveling Nurse Cheers up Kids with Handmade Books 3Health News:Greg Lawson Americana Photography Gift Books Now Offered with Free Shipping Worldwide 2
...ngines.com says Mednar is the "hands down winner" ...s, Mednar has been named the 2008 best health info... well-respected blog that focuses on specialty sea...t enables users to quickly access information from...
... CITY, China, Jan. 21 /PRNewswire-Asia-FirstCall/ ...TC Bulletin Board: CPHI), which develops,manufactu... in China, today,announced a financial preview. , ...,accounts receivable collection led to clear impro...
...Va., Jan. 21 Insmed Inc. (Nasdaq: INSM ), a dev...als, and Premacure AB, a biopharmaceutical company...evention of complications in neonates due to prema...own as mecasermin rinfabate, for the prevention of...
...pany joins grocers and food suppliers in pulling p...to eat anything but jars of peanut butter while pr...thDay News) -- The number of people sickened in th...lth officials. , Meanwhile, peanut butter products...
...cheduled for Week of January 26, 2009 , , ROANO...ions Research Institute (HCRI - www.stuttering.or...treatment innovation, have just completed successf...uations. , , To view the Multimedia News Release,...
...ll Earn Decision Resources, Clinical Gold-Standard...from Decision Resources , , WALTHAM, Mass., Jan. ... research and advisory firms for pharmaceutical an...ion when compared with Amgen/Wyeth/Takeda,s Enbrel...
Other Medicine News:Health News:Deep Web Technologies' Mednar Is Rated the #1 Alternative Health Search Engine 2Health News:Deep Web Technologies' Mednar Is Rated the #1 Alternative Health Search Engine 3Health News:China Pharma Holdings, Inc., Financial Year 2008 Preview 2Health News:China Pharma Holdings, Inc., Financial Year 2008 Preview 3Health News:Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants 2Health News:Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants 3Health News:Salmonella Infection Numbers Still Rising 2Health News:Salmonella Infection Numbers Still Rising 3Health News:Salmonella Infection Numbers Still Rising 4Health News:Photos: Apple's iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute 2Health News:Photos: Apple's iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute 3Health News:An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe 2Health News:An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe 3
(Date:12/3/2009)...TAWAY, N.J., Dec. 3 Mile...the recognized leader in advanced injection techno... joint venture with China National Medicines Corpo...ell Pharmaceutical Co. Ltd., both incorporated in ...elop orthopedic and epidural drug delivery instrum...
(Date:12/3/2009)...GROVE, Minn., Dec. 3 Upsher-Smith ...of its strategic plan for central nervous system (...mate), an internally developed program for the man...h Upsher-Smith,s proprietary formulation technolog...ly 2010 for the adjunctive treatment of epilepsy p...
(Date:12/3/2009)...N.Y., Dec. 3 VirtualScop... quantitative imaging for clinical trials, announc... for 4D Reconstruction and Visualization" recently... Vice President of Technology and Product Developm...at Japan has recognized the uniqueness of VirtualS...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3Canadian researchers discover gene related to the appearance of aging 13047 1Canadian researchers discover gene related to the appearance of aging 13047 2Gene Mutation Is Linked to Heart Muscle Disease 51799 1Gene Mutation Is Linked to Heart Muscle Disease 51799 2Memory Forms at 30 Weeks in the Womb 51797 1Memory Forms at 30 Weeks in the Womb 51797 2Memory Forms at 30 Weeks in the Womb 51797 3
...ikely to subsequently,respond, have substantially ... change in treatment strategy, COLORADO SPRINGS, C... data presented at the 2007 International Congress...tipsychotic drug,response be assessed earlier than...chizophrenia treatment paradigm for when to,evalua...
...oid Plaque Formation, ANNAPOLIS, Md., April 03, 20...odefense company specializing in the development,a...ainst chemical,and biological terrorism, announced...holinesterase (rBChE) research program were,recent...n,Alzheimer,s and Parkinson,s Diseases in Salzburg...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6
...t™ HME product line has the right product fo...d from intubated patients to patients with tracheo...on for both anesthesia and critical care applicati...maximum protection for patients and staff members....
...copic condenser humidifiers (HCH) capture the pati... the inspired gas. Small and compact, they are spe...scopic benefits. Depending on the tidal volume req... model., ,The adult HCH is ideal for patient tida...
...copic condenser humidifiers (HCH) capture the pati... the inspired gas. Small and compact, they are spe...scopic benefits. Depending on the tidal volume req... model., ,The adult HCH is ideal for patient tida...
HCSMC701NF HME w/CO2 Sampling Port
Medicine Products: